Biomarker analysis can be used not only for exploratory studies and internal decision making, but also as a surrogate clinical endpoint. InnoStar biomarkers and translational research platform provides flexible and fit-for-purpose strategies to facilitate translational drug research ranging from biomarker discovery to clinical applications. The platform can provide protein biomarker detection (including different combinations of cytokines, inflammatory factors, and chemokines, biomarkers for different diseases, etc.), receptor occupancy analysis, pathology analysis (multiplex immunohistochemistry, multiplex immunofluorescence, in situ hybridization, and fluorescence in situ hybridization) and studies on genomics (NGS, single cell sequencing and CITE-seq), proteomics, spatial omics, in vivo targets and others.
● Experienced and technologically-competent research teams
● Advanced instruments and equipment and multi-dimensional technical platform
● Data complying with GLP and GCP standards ensure the reliability of translational research
● Integrated platform with high-quality combining clinical and clinical research
● New collaboration model for translational research
Copyright © 2017-2021©中国·手机球探(bet007认证)官方网站-Macau App Station. All Rights Reserved. Created By VPABrand.com